You just read:

MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer

News provided by

MabVax Therapeutics Holdings, Inc.

18 Jul, 2016, 08:00 ET